NCT05950971

Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation

Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation After Non-cardiac Non-thoracic Surgery

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Adult patients who are diagnosed new onset atrial fibrillation with rapid ventricular response within 7 days after non-cardiac non-thoracic surgery are enrolled.

Detailed description

After randomization, they are allocated to rhythm control strategy group or rate control strategy group. In rhythm control strategy group, patients are given amiodarone primarily for the purpose of sinus conversion of cardiac rhythm. In rate control strategy group, patients are given diltiazem or esmolol for the purpose of rate control. the rate of sinus conversion within 48 hours after treatment are compared.

Conditions

• Atrial Fibrillation New Onset
• Atrial Fibrillation Paroxysmal

Interventions

Type	Name	Description
DRUG	Amiodarone, diltiazem or esmolol	Intravenous continuous infusion after loading or bolus dose of amiodarone, diltiazem or esmolol.

Timeline

• Start date: 2021-07-01
• Primary completion: 2022-01-21
• Completion: 2022-01-21
• First posted: 2023-07-18
• Last updated: 2023-07-18

Locations

1 site across 1 country: South Korea